There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Serum carbohydrate antigen (CA 19-9) is the most common tumor marker assessed in pancreatic
cancer patients; nevertheless few articles have comprehensively evaluated the evidence
for its utility in pancreatic cancer management.